Autolus Therapeutics (AUTL) Short-term Investments (2018 - 2026)

Autolus Therapeutics (AUTL) has 8 years of Short-term Investments data on file, last reported at $196.6 million in Q4 2025.

• Quarterly Short-term Investments fell 45.49% year-over-year to $196.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $196.6 million (down 45.49% YoY) and the FY2025 annual result came in at $196.6 million, down 45.49% from the prior year.
• Short-term Investments slipped to $196.6 million in Q4 2025, from $281.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $420.8 million in Q1 2025 to a low of $210000.0 in Q2 2021.
• A 5-year average of $79.9 million and a median of $601500.0 in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2021 — Short-term Investments slumped 73.28% — and 2024, when it soared 46797.66%.
• Tracing AUTL's Short-term Investments over 5 years: stood at $338000.0 in 2021, then decreased by 3.85% to $325000.0 in 2022, then soared by 136.62% to $769000.0 in 2023, then soared by 46797.66% to $360.6 million in 2024, then sank by 45.49% to $196.6 million in 2025.
• The last three Short-term Investments figures came in at $196.6 million (Q4 2025), $281.3 million (Q3 2025), and $330.5 million (Q2 2025), per Business Quant data.